Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants
NCT04987333
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Inflammatory Diseases
Interventions
DRUG:
Efavaleukin alfa
Sponsor
Amgen